Samsung Bioepis headquarters in Yeonsu-gu, Incheon (Samsung Bioepis) Samsung Bioepis stated Friday it has reached an agreement with US-based firm…
Read More
A Look at Teva (NYSE:TEVA) Valuation Following Launch of Europe’s First Lucentis Biosimilar in Pre-Filled Syringe
Teva Pharmaceutical Industries (NYSE:TEVA), along with Formycon AG and Bioeq AG, has launched FYB201/Ranivisio in Europe as the first Lucentis…
Read More
European Commission grants marketing authorisation to aflibercept biosimilar EYLUXVI (ALT-L9)
Image credit: ©everythingpossible – stock.adobe.com The European Commission (EC) has granted marketing authorisation for EYLUXVI (ALT-L9), an aflibercept (Eylea) biosimilar…
Read More
Aurobindo Pharma’s CuraTeQ Biologics secures UK MHRA approval for biosimilar Dazublys
Aurobindo Pharma Limited announced that its step-down subsidiary, CuraTeQ Biologics s.r.o., has received marketing authorisation from the UK’s Medicines and…
Read More
